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Abstract
Superoxide dismutase (SOD) is a crucial enzyme required to maintain the redox 
potential of the cells. It plays a vital role in protecting normal cells from reactive 
oxygen species (ROS) produced during many intracellular pathogens infections. 
SOD removes excess superoxide radicals (O2−) by converting them to hydrogen 
peroxide (H2O2) and molecular oxygen (O2). Several superoxide dismutase enzymes 
have been identified based on the metal ion as a cofactor. Human SOD differs from 
the intracellular pathogens in having Cu/Zn and Mn as metal cofactors. However, 
SOD of intracellular pathogens such as Trypanosoma, Leishmania, Plasmodium, 
and Mycobacterium have iron (Fe) as metal cofactors. Iron Superoxide Dismutase 
(FeSOD) is an essential enzyme in these pathogens that neutralizes the free radi-
cal of oxygen (O−) and prevents the formation of Peroxynitrite anion (ONOO−), 
helping the pathogens escape from redox-based cytotoxic killing. Moreover, most 
intracellular bacteria hold MnSOD or FeSOD in their cytoplasm such as Salmonella 
and Staphylococcus, whereas periplasm of some pathogenic bacteria and fungi are 
also cofactors with Cu/Zn and identified as CuZnSOD. This chapter will review the 
various types SOD present in intracellular pathogens and their role in the survival 
of these pathogens inside their host niche.
Keywords: Superoxide dismutase, Intracellular Pathogen, Reactive oxygen species, 
Antioxidant enzyme
1. Introduction
Reactive oxygen species are primarily the result of the by-product of the redox 
process and may also be produced to initiate intracellular signaling and antimicro-
bial activity. The general phenomenon is to maintain the ROS level in the cell by 
antioxidant enzymes and antioxidants molecules present in cells [1]. One of the 
prime sources of ROS in mammalian cells is the respiratory chain in mitochondria. 
It’s well established that ROS generation is an essential modulator of inflamma-
tory reactions in mammals. The enzyme NADPH oxidase induced the oxidative 
burst, leading to a dramatic increase in oxygen consumption and increasing the 
phagocytosis process. Activated macrophage induced the expression of IFN-γ and 
TNF-α cytokines, improving NADPH oxidase activity resulting in ROS production, 
such as oxygen-free radicals (O2
•−) superoxide. The O2
•− species are converted into 




by spontaneously or enzymatic reaction [2, 3]. Activation of nitric oxide synthase 
(iNOS) or (NOS2) protein in macrophage stimulates the increased secretion of 
nitric oxide (NO) and •NO-metabolite levels within the cell. ROS is the first super-
oxide radicals produced by mitochondria. ROS is a highly reactive oxygen species 
and does not diffuse quickly from cells since the leading site of ROS production is 
in the inner mitochondrial membrane. H2O2 is derived from mitochondrial ROS 
and detoxified by superoxide dismutase. ROS detoxification has been assigned in 
ROS-generating sites in the cell, such as mitochondria, glycosome, endoplasmic 
reticulum, and cytosol. Hydrogen peroxide (H2O2) is not considered a free radical 
by definition since it lacks free electrons. Still, NO is deemed to be free radicals, has 
also been involved in ROS-mediated damage. However, NO has a dual nature, like as 
beneficial as well as vicious [4–6].
Aerobic organisms exhibited two major antioxidant defense systems to minimize 
the ROS-mediated damage occurring due to oxygen-free radicals. The first one is 
enzymatic defense, and the second is low molecular weight antioxidants such as 
vitamins and phytochemicals. In general, cells control oxidative stress by three 
essential antioxidant enzymes which are present in it; (i) Superoxide dismutase is 
a class of oxidoreductase enzymes that contain metal ions in their active site (Fe or 
Mn and/or Cu/Zn) and is responsible for converting superoxide anion into H2O2. 
(ii) glutathione peroxidase is responsible for the reduction of H2O2 into hydroper-
oxides using glutathione as hydrogen donor, and (iii) catalase is responsible for the 
breakdown of H2O2 into O2 and H2O [7]. Since the activity glutathione peroxidase 
is required glutathione as hydrogen donor. Thus, the NADPH-dependent reduction 
of oxidized glutathione to maintain a steady state of glutathione is needed for GSH 
activity [1].
Superoxide dismutase catalyzes the dismutation of oxygen free radical to O2 and 
H2O2 in the cell. SOD enzymes also participate in signaling pathways by controlling 
ROS action and protecting the cells from the toxic effects of superoxide radicals. 
Intracellular SODs mainly restrict superoxide action, which harms the cells by 
damaging the Fe-S cluster-containing enzymes. Extracellular SODs also guard the 
cells from superoxide released by the host or pathogens. For example, extracellular 
SODs of microbial pathogens are protected by ROS-mediated killing of host cells. 
The host cells antioxidant system includes enzymes such as SOD, catalases, and 
peroxidases [8, 9].
2. Superoxide dismutase
The evolutionary history of metalloenzyme superoxide dismutase (SOD) is aged 
and has been there before the differentiation of eubacteria from archaea bacteria. 
It is ubiquitous protein present in all living organisms and plays a vital role in the 
extreme pressure defense against superoxide radicals in the cell. The SOD catalyzes 
the conversion of the two molecules of virulent oxygen free radical (O−) into 
molecular oxygen (O2) and hydrogen peroxide (H2O2) by using two equivalents of 
H+ ions [10]. SOD is marked as a strong free radical scavenger that can eliminate 
the toxic effects of superoxide produced during the reduction of molecular oxygen. 
SODs enzyme family have been classified based on several factors, and one is on the 
metal ion. In general, SODs contain the metal cofactor at their catalytic core and are 
classified into three major groups: copper/zinc (Cu/Zn-SOD) [11, 12], manganese 
(Mn-SOD) [13], and iron (Fe-SOD) [14–16]. SOD containing MnSOD, FeSOD 
and CuZnSOD are encrypted by the gene sodA, sodB, and sodC, respectively. 
Nickel (Ni)- and iron-zinc (Fe/Zn) containing isozymes have also been identified 
in several bacteria [17, 18]. FeSOD has mainly reported in prokaryotes except few 
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protozoan parasites, whereas MnSOD and CuZnSOD are found in both prokaryotes 
and eukaryotes. All these isoforms were identified based on their diverse sensitivi-
ties to cyanide (CN) and H2O2. The Cu, Zn-SOD is extremely sensitive to CN and 
H2O2 [19]. Mn-SOD is insensitive to CN and H2O2 [20], while Fe-SOD is not sensi-
tive to CN but sensitive to H2O2 [21]. In addition, Mn-SOD and Fe-SOD, both were 
inhibited by chloroform–ethanol, but Cu, Zn-SOD is insensitive [22].
Moreover, SODs of intracellular bacteria are further classified into three groups 
based on their localization; Mn- and Fe-cofactor SODs are found in the cytosol. In 
contrast, the third one of SOD cofactor by Cu-Zn and is attached with periplasm 
or anchored with the lipid of the outer envelope [23, 24]. Cu/Zn-SOD of bacteria 
dismutase superoxide produced by host cell during phagocytosis contributes to 
helping bacterial virulence [25, 26]. Additionally, few families of SODs also use 
a Ni ion as cofactor at their catalytic core to initiate its functions [27]. A study 
has shown that superoxide dismutase from Streptococcus is capable of making a 
cofactor substitution with Fe in place of Mn [28]. On the other hand, Leishmania 
tropica, Trypanosoma brueci, and Crithidia fasciculate have superoxide dismutase, 
which is insensitivity to cyanide but sensitive to azide and peroxide [29]. SODs of 
Trypanosomatids are having Fe as a metal cofactor at their catalytic core and are 
categorized as iron superoxide dismutase (Fe-SOD). Other protozoan parasites 
also have the same Fe-SOD, such as Plasmodium falciparum and Entamoeba histo-
lytica, where enzyme-mediated free radical catabolism is fully Fe-SOD dependent 
[30]. Fe-SOD isoform was first discovered in Escherichia coli in 1973 by Yost and 
Fridovich. Subsequently, the same isoform was characterized in T. cruzi in 1977. 
Like Trypanoredoxin (TR), SODs of T. cruzi differ from the mammalian host. 
Trypanosomatids, other protozoan parasites (P. falciparum and E. histolytica), some 
plants, and Archaea possess only Fe-SOD. However, humans and other mammalian 
hosts contain Cu/Zn-SOD and Mn-SOD as core metal Figure 1 [31].
This chapter will discuss role of superoxide dismutase in various intracellular 
pathogens that are belong to protozoan parasites genus Trypanosoma, Leishmania, 
Plasmodium and Toxoplasma, bacterial intracellular pathogens belongs to genus 
Mycobacterium, Salmonella, Francisella and Staphylococcus and fungal intracellular 
pathogens belongs to genus Cryptococcus and Histoplasma etc.
Figure 1. 
Schematic representation of SOD localization in intracellular pathogens and SOD chemical reaction.  
A) Localization of SOD in bacterial pathogens, B) localization of SOD in protozoan and fungal pathogens 
and C) SOD reaction in mitochondria of protozoan and fungal pathogens.
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3. Role of SOD in intracellular parasites
There are several intracellular protozoan parasites which are causing severe 
illness in human’s beings and if left untreated 100% mortality. These intracellular 
parasites belonging to the genus Plasmodium, Leishmania, and Trypanosoma, caus-
ing a spectrum of diseases like malaria, Leishmaniasis, African sleeping sickness, 
and Chagas disease in humans [1]. Antioxidant defense of pathogenic protozoan 
parasites is significantly distinct from each other as well as compared to their mam-
malian host. Trypanosomatids, as well as Plasmodium species have an Fe-containing 
SOD isoform, which is typically found in bacteria but absent in other eukaryotic 
cells [32, 33]. The main function of Fe-SOD is to neutralizing the O[−] that are 
formed during the generation of the superoxide radical [34]. Parasite persistence is 
determined by a balance between the ability of the immune response and resistance 
against free radicals produced by host cells. Leishmania-infected macrophages are 
able to produce inflammatory cytokines, ROS, and •NO derivatives, which usually 
lead to the killing of the phagocytosed microorganism. However, Leishmania and 
Trypanosoma spp. are few protozoa that can survive and resist cytotoxic environ-
ments within the macrophage, and further, they can able to replicate in such a 
hostile condition Table 1 [4, 5].
3.1 Trypanosomiasis
Chagas is a parasitic disease caused by intracellular parasites Trypanosoma 
cruzi. The prevalence of the disease is around 6–7 million worldwide, mainly in 
Latin America and listed in 17 neglected tropical diseases (NTD) classified by the 
WHO (WHO-2021). The present chemotherapy is relay on two available drugs 
5-nitrofurannifurtimox (NFX) and 2-nitroimidazole benznidazole [65]. T. cruzi 
contains only Fe-dependent superoxide dismutase (Fe-SOD). Parasites have two 
dimeric Fe-SOD isoforms, one mitochondrial and one cytosolic isoform. However, 
Mateo et al. [35] investigated and characterized 4 Fe-SODs in T. cruzi epimasti-
gotes, mainly cytosolic. The level of Fe-SOD increases during the differentiation of 
short stumpy forms of the parasite into dividing procyclic forms [66]. Therefore, 
Fe-SODs could be a promising drug target for the development of anti-chagasic 
drugs because of their exclusivity in T. cruzi. Furthermore, the crystal structures 
of the cytosolic Fe-SOD and the mitochondrial Fe-SOD from T. cruzi suggest that 
each enzyme has two polypeptide chains and two active sites composed of a Fe2+/
Fe3+ ion, respectively. In Chagas disease, phagocytosis of parasites by macrophages 
is the first line of defense against the parasites by the host. Macrophage produces 
superoxide radical (O2 •−), which diffuses into parasitophorous vacuoles, causing 
toxic environments to the parasites. However, T. cruzi is also equipped with an 
antioxidant network to counter the host-derived ROS activity. During infections, 
parasites are internalized into the phagolysosomal compartment and activate the 
NADPH oxidase 2 complex (Nox2) of the host macrophage [67]. Nox2 activity in 
macrophages results in intraphagosomal formation of oxygen free radicals (O2•−) 
and O2•− derived ROS, which is required to neutralize parasite proliferation and 
disrupt its differentiation in the early stage of infection. Macrophages derived from 
Nox2-deficient (gp91phox−/−) mice produced marginal amounts of superoxide 
radical and are more susceptible to parasite infection than those macrophages 
derived from wild-type mice. Nox2-derived superoxide radical plays a crucial role in 
controlling T. cruzi infection in the early phase of a murine model of Chagas disease 
[68]. Inhibition or ablation of the Nox2 enzyme has shown to be detrimental for 












Infectious Group Disease Agent Major metal ions Sub-class of SOD Role of SOD in Pathogenesis Reference
Parasitic disease Trypanosomiasis Trypanosoma cruzi, T. bruci Fe-SOD SOD-B1 & B2, SOD-A & 
SOD-C
Increase the resistance of parasite and 
decrease ROS mediated phagocytic killing
[30, 35]
Leishmaniasis Leishmania major, L. donovani, 
L. tropica, L. major, L. chagasi
Fe-SOD SOD-A, SOD-B1 & B2 Increase the virulence of the parasites and 
decrease ROS-mediated phagocytic killing
[36–39]
Malaria Plasmodium falciparum, P. 
ovale, P. malariae, P. vivax
Fe-SOD SOD-1 & 2 Limit the toxicity of ROS produced during 
hemoglobin degradation
[40–43]
Toxoplasmosis Toxoplasma gondii Fe-SOD SOD-B1, SOD2 & SOD3 Increased the intracellular growth of 
parasites. Triggered the humoral and 
cellular immune responses
[44–46]




SOD-B SOD-C Inhibits the iNOS activity, IFN-γ expression 
& control apoptosis and TLR2 expression 
and signaling
[25, 47, 48]
Salmonellosis Salmonella typhimurium, Mn-SOD, Cu/
Zn-SOD
SOD-A SOD-C Neutralizing the ROS mediated activity and 
inducible nitric oxide synthase activities and 
increase the virulence
[49–52]
Tularemia Francisella tularensis Fe-SOD, Cu/
Zn-SOD
SOB-B, SOD-C Limits the iron requirement to produce the 
highly lethal OH· free radicals. Increase the 
virulence of bacteria
[53–56]
Boils and Toxic 
shock syndrome
Staphylococcus aureus Mn-SOD Fe-SOD SOD-A SOD-M Increase the resistance to oxidative stress, 
and induced virulence and infection
[57–59]
Fungal Disease Cryptococcosis Cryptococcus neoformans Zn-SOD, Mn-SOD SOD1 SOD-2 Increase the virulence factor and menadione 
resistance
[60–63]




Distribution of superoxide dismutase (SOD) & their sub-class in various intracellular pathogens and their role in pathogenesis of respective diseases.
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Trypanosoma brucei is an obligate intracellular protozoan parasite that causes 
sleeping sickness in humans in many countries of sub-Saharan Africa. Various 
sub-species of parasites cause the disease and responsible for more than 90% of 
all trypanosomal diseases in humans [71]. Overexpression of SOD-B1 in T. brucei 
has shown hypersensitivity to a trypanocidal agent such as benznidazole and 
gentian violet. A similar study in L. chagasi revealed that an increase in SOD-B1 
protein leads to resistance toward paraquat and nitroprusside [72]. Deleting one 
copy of Sod-B1 gene in the L. chagasi increased the sensitivity to the drug and a 
significantly decreased the parasites survival within the host macrophage. T. brucei 
serves four SOD isoforms, of which three are iron-dependent, which is typically 
very much similar to prokaryotic SODs. Localization studies reveal that out of four 
SOD, two are predominantly found in the glycosome (TbSOD-B1 and TbSOD-B2), 
and the other two are found in mitochondria (TbSOD-A and TbSOD-C) [30]. 
Overexpression of cytosolic Fe-SOD-B of T cruzi showed more resistance to the 
phagocytic killing of macrophages and increased intracellular proliferation than 
wild-type (WT) parasites. Fe-SOD-B overexpressed mutant parasites showed 
higher infectivity than WT but lost in gp91-phox−/− macrophages, emphasizing 
the role of O2 •− in parasite killing [67]. TcFeSOD-A gene amplification increases the 
TcFeSOD protein expression and enzyme activity in a T. Cruzi induced resistance 
to benznidazole and gentian violet treatments [44]. The reduced expression of 
TbSOD-B leads to rapid accumulation of superoxide anion within the trypanosome 
responsible for detoxifying highly toxic radical in the parasite [74].
3.2 Leishmaniasis
Leishmaniasis is an intracellular protozoan disease caused by Leishmania 
parasites. Leishmaniasis is usually prevalent in tropical and subtropical regions 
of the world [36, 75]. Leishmania parasite infects host macrophages, survives in 
parasitophorous vacuoles of the macrophage, and escapes from the oxidative killing 
of the parasite by neutralizing the ROS activity. Leishmania Fe-SOD can be clas-
sified into two types based on their localization: FeSOD-A isoform is localized in 
mitochondria, and is related to cellular respiration; FeSOD-B1 and FeSOD-B2 are 
localized in glycosomes and reduce the oxidative stress generated from cellular 
reactions [37]. L. major contains Sod-B1, Sod-B2, and Sod-C genes on chromosome 
32 and sod-A gene on chromosome 8. Sod-B1 and Sod-B2 genes are organized in 
tandem in both L. chagasi and L. donovani. Metacyclic promastigote of L. amazo-
nensis, when lacking one allele of the Sod-A gene, failed to replicate in macrophages 
and severely attenuated their ability to established the cutaneous lesions in mice. 
In addition, the reduction of SOD-A expression in parasites resulting in increased 
susceptibility to oxidative damage. The failure of SODA/sod-A functions in promas-
tigotes compromised their differentiation into axenic amastigotes. Hence, SOD-A 
promotes Leishmania virulence by protecting the parasites against oxidative stress 
and initiating ROS-mediated signaling mechanisms, which are required to deter-
mine infective forms [37]. L. chagasi SOD-B1 null mutant parasites are not viable 
inside host macrophages. Furthermore, parasites lacking one SOD-B1 allele have 
markedly reduced their viability [38]. Moreover, WT and SOD-B1/Δsodb1 L. major 
promastigotes have equal capacity to establish infection in murine bone marrow 
macrophages. However, in contrast to WT parasites, L. major SOD-B1/Δsodb1 
deficient parasites are declined in number over time in macrophages. The results 
suggesting its normal level of SOD-B1 is required for L. major endurance in macro-
phages and virulence in mice [76]. The Fe-SOD transcript level and enzyme activity 
are higher in the amastigote than in the promastigote stage of the parasite when 
treated with nitroprusside and parquet in L. chagasi [72]. In Leishmania, FeSOD-A 
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appears to be the first line of defense against ROS and is crucial for parasite survival 
inside macrophages. Antimony (SbIII) resistant L. (Viannia) brazilensis (LbSbR) 
and L. (Leishmania) infantum (LiSbR) lines express higher FeSOD-A specific 
enzyme activity compared to wild type control and showed more resistance toward 
Antimony (SbIII) [77, 78]. Moreover, miltefosine resistant L. donovani are able 
induce the overexpression of LdFeSODA to protects from drug-induced cytotoxic-
ity, reduces superoxide generation, and involves in suppression of oxidative stress-
induced programmed cell death by reducing the phosphatidylserine exposure, DNA 
damage [79, 80]. Increased exposure of L. donovani to miltefosine makes resistance 
due to the release of LdFeSOD-A into the cytosol from mitochondria. This release 
of LdFeSOD-A into the cytosol or the inhibition of LdFeSOD-A import into the 
mitochondria makes the mitochondria even more susceptible to oxidative stress 
due to the accumulation of ROS. Mitochondria of the parasite are more vulnerable 
to ROS, leading to programmed cell death, emphasizing its role in keeping healthy 
mitochondria [39].
3.3 Malaria
Malaria is caused by an intracellular protozoan parasite belongs to the genus 
Plasmodium. Malaria is endemic in most of tropical countries and subtropical 
regions of Asia, Africa, South, and Central America. Plasmodium can differentiate 
and replicate inside hepatocytes, and then released as merozoites into the blood-
stream, which subsequently invades red blood cells (RBCs) [81]. Plasmodium para-
site uses SOD to reduce the toxicity of ROS throughout the intra-erythrocytic stage 
of parasite survival. The SOD activity in Plasmodium falciparum and rodent malaria 
species is characterized as iron-dependent and the first level of the antioxidant 
defense system of the parasite [40, 81, 82]. P. falciparum consists two distinct genes 
coding for different SOD such as PfFeSOD-1 and PfFeSOD-2 [40]. PfFeSOD-1 is a 
cytosolic protein and expressed during the intra-erythrocytic cycle of the parasite 
[41, 83]. FeSOD-1 is also reported in P. ovale, P. malariae, and P. vivax and very close 
apicomplexan parasites such as Toxoplasma gondii [42]. Since FeSOD-1 is a cytosolic 
protein, it is unlikely to act on a superoxide anion in the parasite food vacuole dur-
ing hemoglobin digestion. Thus, it is plausible that parasites might be taking a large 
amount of Cu/Zn-SOD from the host erythrocyte to detoxify the superoxide anions 
in their organelles [84]. Plasmodium parasite utilizes SODs enzymes to limit the 
toxicity of ROS produced during hemoglobin degradation in the erythrocytic cycle. 
These enzymes play a crucial role in parasite persistence and their intracellular 
survival during the intra-erythrocytic stage of the life cycle. FeSOD1 of Plasmodium 
vinckei (PvSOD1) also plays a central role in the oxidative defense of these parasites. 
However, PvSOD1 is inhibited by H2O2 and peroxynitrite, but not by cyanide and 
azide [85]. The FeSOD-2 of P. falciparum is a mitochondrial SOD with an elongated 
N-terminal protein extension, reminiscent of a bipartite apicoplast-localized 
protein [43, 86]. An inhibition study of recombinant P. falciparum FeSOD suggested 
that SOD is a highly selective drug target to designed antimalarial drugs. The study 
further identified many antimalarial drugs which have shown antimalarial activities 
against P. falciparum and even a strain moderately resistant to chloroquine [87].
3.4 Toxoplasmosis
Toxoplasma gondii is an obligate intracellular protozoan pathogen that infects 
nearly all warm-blooded animals. Toxoplasmosis is one of the most prevalent 
parasitic diseases, an estimated one-third of the global population are at risk. Still, 
it is considered a neglected parasitic disease [88]. T. gondii causes life-threatening 
Reactive Oxygen Species
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illnesses in developing fetuses and in persons with immunocompromised [89]. In 
chronic infection, T. gondii spreads in various organs such as the heart and brain 
through the circulatory system [90]. T. gondii RH tachyzoites treated with resvera-
trol and pyrimethamine significantly increased SOD activity to restrain ROS action 
for their survival [44]. Interestingly, human macrophages failed to produced ROS 
during T. gondii-infection [91], possibly due to an immune evasion mechanism 
of parasites. T. gondii targets the host NADPH oxidase enzyme by reducing the 
expression of Nox4 transcript and protein, resulting in diminished the release 
of intracellular ROS. In infected cells, Nox4 gene expression was associated with 
activation of PI3K/AKT signaling [92]. However, superoxide dismutase and catalase 
enzymes might be playing a role in intracellular survival but, it does not have a 
basis for differences in virulence to mice [93]. In T. gondii, SODs are found in nearly 
all developmental stages of parasites, suggesting their importance in detoxifying 
superoxide radicals to protect the parasite. T. gondii contains three types of SOD; 
SOD-B1 (Fe-SOD), different from the Mn-binding SOD of humans. SOD-B1 is a 
cytoplasmic and essential enzyme, and SOD-B1 gene knock-outs lead to be lethal 
for parasites [94, 95]. SOD2 and SOD3 are found in the mitochondria of parasites 
and have conserved residues to bind iron. However, they are very similar in the 
primary sequence to SODs from P. falciparum [45] T. gondii superoxide dismutase 
(TgSOD) also affects the intracellular multiplication of both bradyzoite and 
tachyzoite forms of parasites. A recombinant DNA vaccine containing the antigen 
gene of T. gondii were elicited high levels of antibodies, a Th1 type of immune 
response with significant production of IFN-γ, and low levels of IL-4 or IL-10 in 
BALB/c mice [96]. Moreover, a DNA vaccine containing the TgSOD gene triggered 
potent humoral and cellular immune responses, and it stimulates biased protective 
immunity against acute T. gondii infection in BALB/c mice [46]. SOD-DNA vaccines 
of L. amazonensis immunized mice were partially protected from parasites once 
challenged. Mice showed a mixed immune response, including the production of 
IFN-γ and IL-4 from CD4+ and CD8+ T lymphocytes [69]. In addition, the SOD 
vaccine of Brugia malayi was also shown to trigger a typical Th1 response against 
infective larvae and microfilariae in jirds with filarial infection [97]. The above 
finding reveals that SOD-dependent vaccines have potential vaccine efficacy, either 
by protein or DNA-based vaccines, to control intracellular pathogen by activating 
the protective Th1 type of immune responses in animals.
4. Role of SOD in intracellular bacteria
There are several intracellular bacteria which are causing severe illness in 
human’s beings and if left untreated 100% mortality. Most pathogenic bacteria 
contain MnSOD or FeSOD in their cytoplasm, while CuZnSOD has been found on 
the periplasm of pathogenic bacteria and played an essential role during phago-
cytosis [11, 23]. In addition to their ability to detoxify free radicals during aerobic 
growth, bacterial SODs are also critical in determining the virulence factors. In 
several intracellular bacterial infections, SOD-C acts as a critical virulence factor, 
and its localization to the periplasmic membrane protects bacteria from ROS 
derived from host cells [49, 98–100]. Moreover, many virulent bacteria maintain 
two copies of the sodC gene [101]. The evolutionary maintenance of an extra sodC 
gene copy indicates that SOD is essential for pathogenic bacteria for their survival 
inside the host niche [101]. These pathogens belong to the categories of genus 
Mycobacterium, Salmonella, Staphylocccus and Francisella, causing spectrum of 
disease like tuberculosis, leprosy, typhoid, boils, furuncles, cellulitis and  
tularemia etc. Table 1.
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4.1 Tuberculosis and leprosy
Mycobacterium is an intracellular bacterium, which is causing two distinct 
disease manifestations in humans, such as Tuberculosis and Leprosy. Tuberculosis 
(TB) is caused by M. tuberculosis, a leading infectious agent that claims millions 
of deaths worldwide/year [102]. M. tuberculosis is encountered several exogenous 
and endogenous redox pressures throughout its pathogenic life cycle. Therefore, 
they use various in-house enzymes to detoxify and neutralize the redox potential 
produced by host cells. Catalase–Peroxidase, Superoxide dismutase, and Alkyl 
Hydroperoxidase are the enzymes involved in the clearance of oxidative stress [47].
M. Tuberculosis is a highly pathogenic bacterium contains Fe-SOD and expresses 
93-fold more superoxide dismutase. In contrast, non-pathogenic mycobacterium M. 
Smegmatis has Mn-SOD, and M. Tuberculosis export more enzyme than M. smeg-
matis [48]. Superoxide dismutase (SOD) of M. tuberculosis is a 207-residue enzyme 
with molecular mass of 23 kDa [103]. Treatment with diethyldithiocarbamate, a 
potent inhibitor of SOD, increased M. lepraemurium survival in murine splenic 
macrophages [104], suggesting that SOD protein is required for the long-term sur-
vival of mycobacterium in vivo [104] M. tuberculosis has two distinct SOD proteins, 
SOD-A and SOD-C. SOD-A is one of the main extracellular proteins contains Mn, 
Fe-SOD. SOD-C is much lower protein contains Cu, Zn SOD, and present in the 
outer membrane of the bacteria. SOD-C was upregulated during phagocytosis by 
macrophage, suggesting its importance in protecting the M. tuberculosis membrane 
against damage from superoxide radicals [25]. SOD of M. tuberculosis scavenge 
oxygen free radicals and inhibits the release of NO by inhibiting iNOS activity. 
It impairs acquired by down-regulating the IFN-γ expression as well as control 
the caspase-dependent apoptosis. SOD also inhibits innate immunity by down-
regulating TLR2 expression as well as control the TLR2 dependent signaling in the 
cells [104].
Mycobacterium leprae is the causative agent of leprosy or Hansen’s disease. M. 
leprae is the single known bacterial pathogen that infects superficial peripheral 
nerves. It is an intracellular pathogen that infects both myelinated and nonmyelin-
ated Schwann cells of the nerve and proliferates within the monocyte/macrophage 
series cells. Peripheral nerves are not protected from the immune response of host 
due to the blood–brain barrier [105]. Hence, the advantage of M. leprae is to escape 
from the phagocytosis actions of the macrophage may be a critical factor in its 
pathogenicity [106]. The SOD activity of M. leprae is lower than the other mycobac-
teria species such as M. lepraemurium, M. phlei [107]. Therefore, the ability to clear 
the M. leprae infection via SOD pathway appeared to be a distinct mannerism and is 
not dependent on macrophage activation and differentiation.
4.2 Salmonellosis
Salmonella typhimurium is a facultative intracellular bacterium that resides within 
modified phagosomes in macrophage promotes replication and escape from kill-
ing by ROS [108]. S. typhimurium infects a wide range of hosts, including animals, 
humans, and poultry. S. typhimurium causes acute gastroenteritis in humans and 
typhoid-like disease in mice. If left untreated, 100% fatal [50]. Salmonella infects 
the epithelial wall of the intestine and escapes from the innate immunity and ROS 
activity of the host. The SOD of S. typhimurium protects the bacterium from exces-
sive ROS activity produced outside or inside of the host cell [109, 110]. Thus, SOD 
was considered a critical factor for bacterial survival by neutralizing the ROS activity 
[111]. The sod-A gene inactivation in Salmonella species is connected with limited 
protection from ROS and decreased virulence during mice infection [26, 109]. 
Reactive Oxygen Species
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sod-A-deficient bacterium displayed a slightly lower growth rate compared to the 
wild-type strain. The loss of the sod-A gene in mutant bacteria harms the ability to 
infect the host cell. Consequently, the sod-A mutant bacterium is highly susceptible 
to the bactericidal action of host cells and has also shown attenuated virulence prop-
erties. More specifically, SOD-A plays a vital role in biofilm formation, increased 
resistance against oxidative stress, and overcome from bactericidal complement 
system of serum [51]. Salmonella combats phagocytic free radicals by producing 
the periplasmic superoxide dismutase. Periplasmic Cu, Zn-cofactor superoxide 
dismutase (SOD-C) protects S. typhimurium from extracellular phagocyte-derived 
oxidative damage by host cells. Salmonella deficient sod-C gene has shown abated 
survival inside the macrophage, increased ROS susceptibility, and attenuated 
virulence factor during in-vivo infection. Conclusively, SOD protects periplasmic or 
inner membrane targets by controlling the phagocytosis-dependent oxidative burst 
or inducible nitric oxide synthase activities during in vivo infection [49]. The evo-
lutionary acquisition of the sod-C gene in Salmonella species extends an increased 
virulence trait of bacterium [52].
However, cytosolic Mn-SOD enzyme is essential for detoxifying intracellular 
superoxide radicals but not involved virulence [112]. SOD of Streptococcus suis 
resistant to anti-oxidative stress and ROS-generating herbicides, which is known to 
cause a severe damage to DNA, RNA, and proteins molecules that might contribute 
to its virulence in mice [53].
4.3 Tularemia
Francisella. tularensis is an intracellular pathogen that causes a disease called 
Tularemia. The disease is considered a potential biological threat for humans due to its 
extreme infectivity and substantial capacity to cause severe illness and death. The hall-
mark of the bacterium is their capability to survive and replicate within macrophages 
[113] and other cell types [114, 115]. The bacterium’s survival depends on its ability to 
combat the microbicidal activity of macrophages such as ROS and reactive nitrogen 
species. F. tularensis require oxygen for their growth and possess ROS-scavenging 
enzymes such as super oxide dismutases, peroxidases, and catalases [116, 117].
Like other bacterial pathogens, F. tularensis contains two types of SOD gene: 
FeSOD (sod-B) and CuZnSOD (sod-C). SOD-B plays a dual role in protecting F. 
tularensis from the oxidative stress of the host. SOD-B binds to the iron with high 
affinity and limits the availability of iron requirement to produce the highly lethal 
OH·. Secondly, detoxification of superoxide prevents cellular damage of DNA, pro-
teins, and lipids associated with O2− toxicity [53, 54]. SOD-B dismutation decreas-
ing the reaction of O2 with NO to form peroxynitrite (ONOO) and protect bacteria 
from ONOO- toxicity [55]. ONOO- has been shown to have a significant role in the 
IFN-γ -induced killing of F. tularensis (live vaccine strain) LVS by murine macro-
phages [99, 118]. However, the genome sequence of F. tulrensis LVS has possessed a 
single functional copy of the sod-B gene [117]. Hence, sod-B gene alteration leads to 
reduced SOD-B enzyme expression might be associated with high sensitivity to oxi-
dative stress suggesting that sod-B is essential for bacterial survival under oxidative 
stress conditions. Therefore, increased survival of mice infected with sod-B mutant 
F. tularensis suggesting that SOD-B plays a role in virulence [56].
A recent study suggests SOD-C (CuZnSOD) of F. tularensis also plays a vital role 
in virulence factors. SOD-C is localized in the periplasm to protect from superoxide 
radicals (O2−) derived from host cells. F. tularensis depleted sod-C (∆sodC) mutant 
and F. tularensis ∆sodC mutant with attenuated sod-B gene expression (sodB 
∆sodC) exhibited attenuated intracellular survival in IFN-γ-activated macrophages 
compared to the wild-type F. tularensis LVS. Transcomplementation of the sod-C 
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gene in ∆sodC mutant bacteria or checking the IFN-γ-dependent production of 
O2− or NO enhanced the survival of the sod mutant’s bacteria in macrophage. The 
virulence capacity of the sodB ∆sodC mutant bacteria was significantly more atten-
uated as compared to ∆sodC mutant. Furthermore, lack of IFN-γ, iNOS, or PHOX 
restored the virulence of ∆sodC mutant strains, suggesting that the CuZnSOD of 
the bacterium is playing a critical role in restricting the bactericidal activities of 
ROS and RNS. The ∆sodC and sodB ∆sodC mutants were also significantly attenu-
ated for virulence in intranasally challenged C57BL/6 mice compared to the wild-
type F. tularensis LVS, indicating that SOD-C is required for resisting host-generated 
ROS and contribute to survival and virulence of F. tularensis in mice [119].
4.4 Staphylococcus (boils and toxic shock syndrome)
Staphylococcus aureus is a gram-positive bacterium, which causes a broad spec-
trum of diseases in humans. It is a facultative intracellular bacterium that invades 
and replicates within many types of phagocytic and non-professional phagocytes 
cells, such as endothelial cells, mammary cells, fibroblasts, and osteoclasts [120]. 
Bacterium commonly symptomatically colonizes in one-third of the population of 
the globe and is a leading cause of antibiotic-resistant [121]. Methicillin-resistant 
S. aureus (MRSA) strains are one of the utmost dangerous species and have shown 
resistance to all β-lactam antibiotics as well as other antimicrobials [122]. S. aureus 
is capable of subverting xenophagy and escaping from the cytosol of the host cell 
during intracellular infection [118, 123, 124]. During intracellular survival, S. aureus 
is capable to protects itself from the oxidative burst by numerous mechanisms, 
including enzymes such as SODs that detoxify the action of ROS activity [125, 
126]. S. aureus serves two distinct SODs, SOD-A and SOD-M, both of which are 
cytoplasmic and reported as Mn-dependent [57, 127]. All Staphylococci species are 
contained SOD-A protein, while S. aureus also has a unique protein SOD-M [58]. 
The loss of either SOD-A or SOD-M in a skin model of infection or loss of both 
SODs in a systemic mouse model of infection diminishes the ability of S. aureus to 
cause disease, highlighting the importance of SOD in the virulence [128, 129].
The lack of both SODs in S. aureus shown bacterium is more sensitive to host 
cells during manganese starvation, suggesting the importance of SOD in overcom-
ing nutritional immunity. Mn starvation in host-mediated protein calprotectin 
reduces staphylococcal SOD activity during in vitro and in-vivo infection. Hence, 
Mn deficiency renders S. aureus more sensitive to oxidative stress and neutrophil-
mediated killing [128, 130, 131]. SOD-A protein is essential for countering oxidative 
stress and disease progression when manganese is abundant. At the same time, 
SOD-M is important under manganese-deplete conditions. However, SOD-A is 
strictly manganese-dependent, whereas SOD-M contains either of two or more 
different metal atoms, having similar enzymatic activity when filled with manga-
nese or iron. During host-dependent Mn starvation, S. aureus enables the ability 
of SOD-M to utilize Fe to retain its SOD activity. Subsequently, S. aureus enhances 
the ability to overcome nutritional immunity, resistance to oxidative stress, and 
ultimately induced virulence and infection [59].
5. Role of SOD in other fungal infection
Superoxide of pathogenic fungus are cofactors with Cu/Zn or Mn metals. The 
enzymes are localized in the cytosol as well as in mitochondria and involved in cell 
differentiation and multi-stress conditions. Mitochondrial Mn-SODs prevent the 
damages of oxidative stress, osmotic and thermal stresses in yeast cells. SODs protein 
Reactive Oxygen Species
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has been shown to contribute to the virulence of many intracellular pathogenic fungi, 
such as C. neoformans [60], and H. capsulatum, both are capable to some degree of 
neutralizing the lethal levels of ROS produced by the host cells [64]. C. neoformans 
have Zn-SOD and Mn-SOD, while H. capsulatum has Cu/Zn-SOD. However, some 
fungal pathogens and fungal-like oomycetes have a unique SOD, such as Cu-SODs 
(SOD5). SOD5 are closely associated with the ubiquitous class of Cu/Zn-SODs but 
lack a Zn cofactor [34] and are believed to act on substrate level [132–134]. Unlike 
Cu/ZnSODs, which is found in both intra- and extracellularly, Cu-SODs are found 
exclusively in extracellular, and they appear primarily appended to the GPI anchors 
protein of cell surface [135, 136]. Cu-SODs have been proved to protect pathogens 
from the oxidative burst of the host regulated by immune cells [9] Table 1.
5.1 Cryptococcosis
Cryptococcus neoformans (Cn) is a facultative intracellular fungal pathogen and 
can propagate inside the host macrophages during many stages of experimental and 
human infections [137, 138]. Cryptococcus is a soil fungus that causes life-threatening 
meningitis in immunocompromised patients [139, 140]. Cryptococcus is an encapsu-
lated pathogenic yeast composed primarily of glucuronoxylomannan (GXM). This 
polysaccharide helps the fungus play a defensive and offensive role during pathogen-
esis. It protects the fungus against phagocytosis and promoting intracellular patho-
genesis through the cytotoxic release of polysaccharides into macrophage vacuoles 
[137]. Cryptococcus rarely causes clinically visible infections in healthy hosts, but it can 
be present in latency and persistence inside macrophages [61, 62]. C. neoformans var. 
gattii predominantly infects individuals having a normal immune response, whereas 
var. grubii and neoformans are common in immunocompromised individuals. C. 
neoformans var. gattii hinders macrophage phagocytic response, whereas the other two 
varieties are readily killed by ROS released by phagocytic cells [141, 142].
C. neoformans is resistance to ROS mediated oxidative killing of macrophage by 
inducing the SOD activity and might be playing an important role in virulence of this 
fungus. Exogenous supplementation of SOD significantly controlled the bacterial 
growth by inducing human neutrophil function, suggesting that SOD plays a protec-
tive role during C. neoformans infection [63]. Cryptococcus neoformans var. gattii con-
tains two types of SODs such as copper, zinc-depend SOD (SOD1) and Mn-dependent 
(SOD2) isoenzymes [143]. Both SOD1 and SOD2 are intracellular SODs, and deletion 
of their encoding genes reduces the fungal virulence in vivo model of infection. 
Furthermore, the mutant fungus also increases sensitivity to pharmacologically-
induced intracellular oxidative stress [144]. The sod1 mutant C. neoformans was shown 
three characteristic features 1) highly sensitivity toward oxidative killing by human 
polymorphonuclear (PMN) cells and by the redox cycling agent menadione. 2) The 
sod1 mutant was markedly attenuated in virulence when raising the infection in mice, 
and it also showed significantly susceptibility to in vitro killing by human neutro-
phils. 3) SOD1 deletion also appeared to be defects in the expression of a number of 
virulence factors such as laccase, urease, and phospholipase. Complementation of 
the sod1 gene mutant C. neoformans with SOD1 protein regained the virulence factor 
and menadione resistance. Hence, the antioxidant function of SOD1 is critical for the 
pathogenesis of the fungus during intracellular survival [60, 142, 145].
5.2 Histoplasmosis
Histoplasma capsulatum is an intracellular fungal pathogen structurally similar 
to yeast cells. H. capsulatum successfully infect host cells like neutrophils and 
macrophages. H. capsulatum is prevalent in the Midwestern United States and 
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Latin America. Macrophages efficiently phagocytize the Histoplasma cells, but they 
failed to kill the fungus despite having ample ROS production. Histoplasma cells 
counter the ROS-mediated oxidative stress of the host by three proteins that are 
possibly involved in defending Histoplasma from ROS. sod1 and sod3 gene deficient 
Histoplasma strains shown the spatial specificity of the SOD1 and SOD3 superoxide 
dismutases for internal and external (i.e., host-derived) superoxide, respectively. 
SOD-3 is the primary source of extracellular SODs, and its expression is signifi-
cantly enriched in the pathogenic phase of fungus cells. Histoplasma SOD-3 offers 
higher resistance of fungus against the phagocytic killing of host cells leading to 
increased capacity to cause disease in immunocompetent hosts. In in vivo studies, 
sod-3 gene deficient Histoplasma strains were shown the attenuation in virulence 
in mice. Furthermore, restoration of ∆sod3 mutant Histoplasma virulence in mice 
unable to produce superoxide radicals conclusively proves that SOD3 functions 
in the detoxification of superoxide generated by the host. SOD-3 also prevents 
the superoxide-dependent killing of Histoplasma yeast cells. The host to control 
the infection of Histoplasma requires ROS production. Hence, SOD-3 is a central 
virulence factor of Histoplasma and help to fungus survives under oxidative stress 
produced by host phagocytic cells during infection [64].
6. Conclusion
Superoxide’s are the critical molecules produced by host cells to counter intracel-
lular pathogens during infection. ROS is mainly produced within mitochondria of 
cells as byproducts of normal cell respiration. Defects in oxidative phosphorylation 
in cells could lead to an increase or decrease in ROS production by host cells. ROS-
mediated destruction can directly affect the components of the electron transport 
system of host cells. Therefore, to reduce the ROS activity, host cells are evolved 
with three types of SODs such as NiSOD, Fe or MnSOD, and CuZnSOD to control 
the ROS activity produced by itself. More importantly, the immune cells of the host 
used ROS as defense molecules against various kinds of human pathogens during 
their infection.
Intracellular pathogens are also furnished with all types of SODs such as NiSOD, 
Fe or MnSOD, and CuZnSOD. Pathogens are using these SODs in neutralizing the 
free radicals produced by host cells during infection. SODs of intracellular patho-
gens can modulate the interaction with phagocytic cells at the onset of phagocytosis 
by altering the local concentrations of superoxide anion in parasitophorous vacuoles 
of host cells. SODs of these pathogens are also required to neutralized O2- gener-
ated by IFN-γ-activated macrophages, but not necessary for survival in quiescent 
macrophages. However, the role of SOD in combating other infection does not 
solely depend on the phagocytic ability of macrophages. In conclusion, SODs of 
intracellular pathogens are the key determinants of their survival inside the host 
niche. Furthermore, it also plays a vital role in the severity of disease and virulence 
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